U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H17NO6
Molecular Weight 367.3521
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BICUCULLINE

SMILES

CN1CCC2=CC3=C(OCO3)C=C2[C@H]1[C@@H]4OC(=O)C5=C6OCOC6=CC=C45

InChI

InChIKey=IYGYMKDQCDOMRE-ZWKOTPCHSA-N
InChI=1S/C20H17NO6/c1-21-5-4-10-6-14-15(25-8-24-14)7-12(10)17(21)18-11-2-3-13-19(26-9-23-13)16(11)20(22)27-18/h2-3,6-7,17-18H,4-5,8-9H2,1H3/t17-,18+/m0/s1

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/15369839 | https://www.ncbi.nlm.nih.gov/pubmed/27780724 | https://www.ncbi.nlm.nih.gov/pubmed/27520081

Bicuculline is a phthalide-isoquinoline compound that is a light-sensitive competitive antagonist of GABAA receptors. It was originally identified in 1932 in plant alkaloid extracts and has been isolated from Dicentra cucullaria, Adlumia fungosa, Fumariaceae, and several Corydalis species. Since it blocks the inhibitory action of GABA receptors, the action of bicuculline mimics epilepsy. This property is utilized in laboratories across the world in the in vitro study of epilepsy, generally in hippocampal or cortical neurons in prepared brain slices from rodents. This compound is also routinely used to isolate glutamatergic (excitatory amino acid) receptor function.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
44.0 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Early onset of glutamatergic and GABAergic synaptic activity in the visual layers of the rodent superior colliculus.
2001-06
Real-time multisite observation of glutamate release in rat hippocampal slices.
2001-05-18
Zn2+ differentially modulates signals from red- and short wavelength-sensitive cones to horizontal cells in carp retina.
2001-05-04
Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
2001-05-01
Seizure-like activity in the disinhibited CA1 minislice of adult guinea-pigs.
2001-05-01
The functional role of a bicuculline-sensitive Ca2+-activated K+ current in rat medial preoptic neurons.
2001-05-01
Ionotropic histamine receptors and H2 receptors modulate supraoptic oxytocin neuronal excitability and dye coupling.
2001-05-01
Effects of serotonin, GABA and neuropeptide Y on seabream gonadotropin releasing hormone release in vitro from preoptic-anterior hypothalamus and pituitary of red seabream, Pagrus major.
2001-05
Effects of retigabine on rhythmic synchronous activity of human neocortical slices.
2001-05
Polysynaptic excitatory pathways induce heterosynaptic depression in the rat auditory cortex.
2001-05
Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux.
2001-05
GABAergic modulation of ventilation and peak oxygen consumption in obese Zucker rats.
2001-05
Unitary synaptic currents between lacunosum-moleculare interneurones and pyramidal cells in rat hippocampus.
2001-04-15
Rapid signaling at inhibitory synapses in a dentate gyrus interneuron network.
2001-04-15
GABA transaminase inhibition induces spontaneous and enhances depolarization-evoked GABA efflux via reversal of the GABA transporter.
2001-04-15
Cataleptic effect of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice: modulation by serotonergic agents.
2001-04-13
Endogenous acetylcholine facilitates epileptogenesis in immature rat neocortex.
2001-04-13
Acute exposure to trichloroethylene differentially alters the susceptibility to chemoconvulsants in mice.
2001-04-12
The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats.
2001-04-06
Functional modulation of gamma-aminobutyric acid(A) receptors by etifoxine and allopregnanolone in rodents.
2001-04-06
Contribution of intralaminar thalamic nuclei to spike-and-wave-discharges during spontaneous seizures in a genetic rat model of absence epilepsy.
2001-04
NMDA-evoked calcium transients and currents in the suprachiasmatic nucleus: gating by the circadian system.
2001-04
Spontaneous GABAergic postsynaptic currents in Cajal-Retzius cells in neonatal rat cerebral cortex.
2001-04
The effects of propofol in the area postrema of rats.
2001-04
Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by gamma-aminobutyric acid(A) receptors in hippocampal neurons.
2001-04
Central GABAergic mechanisms are involved in apnea induced by SLN stimulation in piglets.
2001-04
Effect of beta-estradiol on voltage-gated Ca(2+) channels in rat hippocampal neurons: a comparison with dehydroepiandrosterone.
2001-03-30
Effects of pituitary adenylate cyclase activating polypeptide on lumbosacral preganglionic neurons in the neonatal rat spinal cord.
2001-03-23
Cardiorespiratory and metabolic responses to injection of bicuculline into the hypothalamic paraventricular nucleus (PVN) of conscious rats.
2001-03-23
Female gastrin-releasing peptide receptor (GRP-R)-deficient mice exhibit altered social preference for male conspecifics: implications for GRP/GRP-R modulation of GABAergic function.
2001-03-16
Involvement of GABA in medullary raphe-evoked modulation of neuronal activity in the periaqueductal grey matter in the rat.
2001-03
Immortalized gonadotropin-releasing hormone neurons (GT1-7 cells) exhibit synchronous bursts of action potentials.
2001-03
Anticonvulsant properties and bio-guided isolation of palmitone from leaves of Annona diversifolia.
2001-03
Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals.
2001-03
GABA(A) receptors in the ventral tegmental area control bidirectional reward signalling between dopaminergic and non-dopaminergic neural motivational systems.
2001-03
Acute phenobarbital administration induces hyperalgesia: pharmacological evidence for the involvement of supraspinal GABA-A receptors.
2001-03
Distinct effect of pregnenolone sulfate on NMDA receptor subtypes.
2001-03
2-deoxyglucose enhances epileptic tolerance evoked by transient incomplete brain ischemia in mice.
2001-03
Immunocytochemical and electrophysiological characterization of GABA receptors in the frog and turtle retina.
2001-03
Excitatory synaptic input to granule cells increases with time after kainate treatment.
2001-03
Expansion of receptive fields in raccoon somatosensory cortex in vivo by GABA(A) receptor antagonism: implications for cortical reorganization.
2001-02
Induction of wakefulness and inhibition of active (REM) sleep by GABAergic processes in the nucleus pontis oralis.
2001-02
The pharmacodynamics of anticonvulsant and subconvulsant effects of ethanol in CBA and C57BL/6 mice.
2001-01
Effects of sweetened ethanol solutions on ethanol self-administration and blood ethanol levels.
2001-01
The polysialylated neural cell adhesion molecule reaches cell surfaces of hypothalamic neurons and astrocytes via the constitutive pathway.
2001
GABA(A) agents injected into the ventral pallidum differentially affect dopaminergic pivoting and cholinergic circling elicited from the shell of the nucleus accumbens.
2001
GABA promotes survival but not proliferation of parvalbumin-immunoreactive interneurons in rodent neostriatum: an in vivo study with stereology.
2001
Fragile X mice develop sensory hyperreactivity to auditory stimuli.
2001
Effects of neurotensin on discharge rates of rat suprachiasmatic nucleus neurons in vitro.
2001
Slow inhibitory potentials in the teleost Mauthner cell.
2001
Patents

Patents

Sample Use Guides

Chicks of 4–6 days old weighing approximately 100 g were used in the experiments. Bicuculline was dissolved in 0.85% saline and intraperitoneally (i.p.)injected at doses of 0.0036, 0.036, 0.36 and 36 mg/kg body weight at a final volume of 100 mkL. The final dose of bicuculline methiodideused for co-administration with ghrelin produced no behavioral effects per se.
Route of Administration: Intraperitoneal
Rat primary cortical cultures was used for study spontaneous and pharmacologically-induced neural network function. Changes in number of total extracellularly-recorded action potential spikes (total spikes; TS) and active electrodes (AE), relative to controls, were assessed 1, 24, and 48 h after exposure to AgNO3. After the 48 h recording, the response to a pharmacological challenge with the GABAA antagonist, bicuculline (25uM), was assessed.
Name Type Language
BICUCULLINE
MI  
Common Name English
NSC-32192
Preferred Name English
BICUCULLINE [MI]
Common Name English
(6R)-6-((5S)-6-METHYL-5,6,7,8-TETRAHYDRO(1,3)DIOXOLO(4,5-G)ISOQUINOLIN-5-YL)FURO(3,4-E)(1,3BENZODIOXOL-8(6H)-ONE
Common Name English
Code System Code Type Description
WIKIPEDIA
BICUCULLINE
Created by admin on Mon Mar 31 19:33:46 GMT 2025 , Edited by admin on Mon Mar 31 19:33:46 GMT 2025
PRIMARY
CHEBI
3092
Created by admin on Mon Mar 31 19:33:46 GMT 2025 , Edited by admin on Mon Mar 31 19:33:46 GMT 2025
PRIMARY
FDA UNII
Y37615DVKC
Created by admin on Mon Mar 31 19:33:46 GMT 2025 , Edited by admin on Mon Mar 31 19:33:46 GMT 2025
PRIMARY
CAS
485-49-4
Created by admin on Mon Mar 31 19:33:46 GMT 2025 , Edited by admin on Mon Mar 31 19:33:46 GMT 2025
PRIMARY
EPA CompTox
DTXSID3042687
Created by admin on Mon Mar 31 19:33:46 GMT 2025 , Edited by admin on Mon Mar 31 19:33:46 GMT 2025
PRIMARY
MESH
D001640
Created by admin on Mon Mar 31 19:33:46 GMT 2025 , Edited by admin on Mon Mar 31 19:33:46 GMT 2025
PRIMARY
PUBCHEM
10237
Created by admin on Mon Mar 31 19:33:46 GMT 2025 , Edited by admin on Mon Mar 31 19:33:46 GMT 2025
PRIMARY
NSC
32192
Created by admin on Mon Mar 31 19:33:46 GMT 2025 , Edited by admin on Mon Mar 31 19:33:46 GMT 2025
PRIMARY
ECHA (EC/EINECS)
207-619-7
Created by admin on Mon Mar 31 19:33:46 GMT 2025 , Edited by admin on Mon Mar 31 19:33:46 GMT 2025
PRIMARY
MERCK INDEX
m2476
Created by admin on Mon Mar 31 19:33:46 GMT 2025 , Edited by admin on Mon Mar 31 19:33:46 GMT 2025
PRIMARY Merck Index
DRUG BANK
DB11562
Created by admin on Mon Mar 31 19:33:46 GMT 2025 , Edited by admin on Mon Mar 31 19:33:46 GMT 2025
PRIMARY